| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |